← Back
$OVID All transactions

Ovid Therapeutics Inc.

▼ SELL

$ Value

$12K

Shares

8,541

Price

$1

Filed

Mar 2

Insider

Name

Rona Jeffrey A

Title

CBFO

CIK

0001311404

Roles

Officer

Transaction Details

Transaction Date

2026-02-23

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

88,188

Footnotes

Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person. | The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $1.45 to $1.49, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | Includes 28,756 shares acquired under the Issuer's employee stock purchase plan. | Represents a restricted stock unit ("RSU") award. The RSUs will vest in three equal annual installments commencing on February 20, 2027, subject to the Reporting Person's continuous service through each such vesting date. | Each RSU represents a contingent right to receive one share of Common Stock. | The shares subject to the stock option will vest in 48 equal monthly installments commencing on March 20, 2026, subject to the Reporting Person's continued services through each such date.

Filing Info

Accession No.

0001311404-26-000002

Form Type

4

Issuer CIK

0001636651

Rona Jeffrey A's History

Date Ticker Type Value
2026-02-26 OVID A $0
2026-02-26 OVID A $0
2026-02-23 OVID $12K

Other Insiders at OVID (90d)

Insider Bought Sold Last
PAPADOPOULOS STELIOS 2026-04-07
LEVIN JEREMY M 2026-02-26
LEVIN JEREMY M
Executive Chairman
2026-03-23
Rona Jeffrey A
CBFO
2026-02-26
DUNCAN BARBARA GAYLE 2026-02-26
Friedman Bart 2026-04-07
Bernstein Karen 2026-02-26
Fitzgerald Kevin Joseph 2026-04-07
ALEXANDER MARGARET A.
President and CEO
$17K 2026-02-26